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Unbiased genetic diagnosis has increasingly associated seemingly unrelated somatic and
immunological phenotypes. We report a male infant who presented within the first year
of life with physical growth impairment, feeding difficulties, hyperemesis without diarrhea,
and abnormal hair findings suggestive of trichorrhexis nodosa. With advancing age, moder-
ate global developmental delay, susceptibility to frequent viral illnesses, otitis media, and
purulent conjunctivitis were identified. Because of the repeated infections, an immunolog-
ical evaluation was pursued and identified impaired antibody memory responses following
pneumococcal vaccine administration. Immunoglobulin replacement therapy and nutri-
tional support were employed as mainstays of therapy. The child is now aged 12 years and
still without diarrhea. Whole exome sequencing identified compound heterozygous muta-
tions in theTTC37 gene, a known cause of the trichohepatoenteric syndrome (THES).This
case extends the known phenotype of THES and defines a potential subset for inclusion
as an immune overlap syndrome.
Keywords: trichohepatoenteric syndrome, primary immunodeficiency, ectodermal dysplasia, trichorrhexis nodosa,
antibody deficiency, chronic diarrhea
INTRODUCTION
Trichohepatoenteric Syndrome (THES) is a rare autosomal reces-
sive disorder characterized by growth restriction, severe infantile
diarrhea, trichorrhexis nodosa-like hair morphology, hepatopa-
thy, facial dysmorphism, and immunodeficiency (1–5). While
THES1 (MIM 222470) is caused by mutation of the TTC37 gene,
THES2 (MIM 614602) results from SKIV2L gene mutations (6–
8). Both genes encode members of the human Ski complex, which
functions in exosomal RNA degradation (8). The clinical fea-
tures of patients with THES1 are indistinguishable from those
with THES2; thus, THES is considered a single entity with two
molecular etiologies (2).
A recent report of 15 patients with THES treated simi-
larly and followed longitudinally showed that 5 year survival
was 86.7% (9). Three (20%) patients died of infectious com-
plications. All 15 patients required total parenteral nutrition
for intractable diarrhea and 9 (60%) required immunoglobu-
lin infusions for variable duration but 10 (67%) patients were
found to have detectable humoral immune defects (9). Two
(13%) of the patients had an inflammatory colitis and nine
(60%) had transient hemophagocytosis. Other THES patients
are reported to have immunologically relevant characteristics
including: abnormal T-cell response to in vitro stimulation;
persistent hypogammaglobulinemia; transient hypogammaglob-
ulinemia; specific antibody deficiency; fatal measles infection; and
inflammatory colitis (6, 8, 10, 11). At present, the immunological
phenotype of THES is neither well characterized nor understood,
but appears to be a significant feature of the syndrome.
BACKGROUND
A Caucasian male infant was born at 36 weeks gestation to unre-
lated parents. His birth length was at the 10th percentile but weight
was <3rd percentile. Early in the first year of life, somatic growth
impairment was evident (weight and length ≤3rd %) and associ-
ated with feeding intolerance. His hair was fine, sparse, and brittle
with a wooly character; facial features were striking (Figure 1).
Diarrhea was occasional, but only intermittent and mild. Vomit-
ing, however, was persistent, often debilitating and associated with
aphthous oral ulcers. He required placement of a gastrostomy tube
at 22 months of age and was hospitalized for implementation of
a feeding regimen shortly thereafter. Gastrointestinal evaluation
including endoscopy was grossly normal.
The patient experienced frequent otitis media, viral infec-
tions, and purulent conjunctivitis despite trimethoprim–
sulfamethoxazole prophylaxis. Simple upper respiratory tract
infections often progressed to presumably bacterial pulmonary
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FIGURE 1 |The patients hair shafts have trichorrhexis nodosa-like
defects (A), and under polarizing microscopy (B) show a somewhat
irregular banding pattern reminiscent of, but distinct from the tiger tail
banding characteristic of trichothiodystrophy. These are not seen in the
polarized view of hair shafts from his brother (C). Pastel colors are artifacts.
(D,E) Show the patients facial features and gross hair morphology at ages 2
and 10 years, respectively. Hair analysis and photos compliments of Alan
Zhou, John J. DiGiovanna, Deborah Tamura, and Kenneth H. Kraemer.
Patient photos courtesy of the family archive, used with permission.
infections requiring additional antimicrobial therapy. Immuno-
logical evaluation of cell counts, lymphocyte proliferation to
mitogens, Toll-like receptor function, and serum quantitative
immunoglobulin concentrations were normal; however, response
to pneumococcal vaccination was abnormal with rapid loss of
protective titers (Figure 2) (12). Immunoglobulin replacement
therapy was initiated at 4 years of age owing to recurring bacte-
rial infections despite continual antibiotic prophylaxis and rapid
pneumococcal-specific antibody titer decline. The patient had no
history of invasive or opportunistic infections and hemophago-
cytosis was absent. Microscopy of our patient’s hair showed tri-
chorrhexis nodosa-like findings similar to those found in other
patients reported with THES, which were (Figure 1) remarkably
different from that of his parents and sibling (9).
In the absence of a clear clinical diagnosis and following acqui-
sition of parental consent, whole exome sequencing was completed
using DNA from ficoll pellet from P1 and his brother (15). After
filtering for rare or non-reported variant, compound heterozy-
gous variants in the TTC37 gene were found (c. 2128C>T and
c. 4337_4338insCTA) in the patient leading to a stop in posi-
tion 710 (R710X) and an in-frame Leu insertion in position 1446
(L1446_A1447insL), respectively suggesting a diagnosis of THES.
FIGURE 2 |Twenty-three valent pneumococcal vaccine response.
Various pneumococcal vaccine serotype titers plotted together before
vaccination and at represented intervals following vaccination with
Pneumovax © at 4, 24, 52, and 60 weeks. Vaccination was performed at
3 years of age following a complete series of the pneumococcal conjugate
(Prevnar 7©) vaccine at recommended ages (AAP schedule) (13). Note the
serotypes indicated with an asterisk (*) indicate those included in the
Prevnar 7 vaccine. For reference, minimally protective titer levels are
accepted to be ≥1.3 mg/dL [Bonilla et al. (14)]. Mean and one standard
deviation are represented for each group. Mean serotype titers for each
time point shown are: 1.4µg/dL (Pre), 3.1µg/dL (4 weeks), 2.4µg/dL
(24 weeks), 1.0µg/dL (52 weeks), and 0.80 g/dL (60 weeks).
Each parent carried one mutation and the healthy sibling had no
defects in the TTC37 gene (Figure 3). The patient subsequently
had a liver ultrasound and hepatic function testing, which were
unremarkable.
Presently at 12 years of age, our patient suffers from recurrent
aphthous ulcers and purulent conjunctivitis without a clear micro-
biological cause. He is small for age but vigorous and of normal
intelligence. He remains on weekly subcutaneous immunoglobu-
lin therapy, which is well tolerated. A reduction in the need for
antibiotics and more robust resistance to infection were noted
since initiating immunoglobulin replacement therapy.
DISCUSSION
Trichohepatoenteric Syndrome is a rare autosomal recessive disor-
der with hallmark clinical findings of growth impairment, severe
diarrhea,hair abnormalities, and immune deficiency (2,6,8,9). We
extend the spectrum of the immunological deficiency associated
with THES in our patient to include specific antibody deficiency
with impairment of humoral memory. Our patient also extends
the somatic phenotype attributed to TTC37 mutation as he did not
have the typical severe diarrhea of infancy characteristic of THES,
despite having the typical hair features. His liver function and
morphology is also normal to this point. Genotype–phenotype
correlations for THES are not well understood; however, our
patient’s lack of severe gastrointestinal symptoms may portend
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FIGURE 3 |TTC37 sequence electropherograms for the four members
of the kindred in the region corresponding to the paternally inherited
c. 2128C>T mutation (upper panel) and the maternally inherited c.
4337_4338insCTA insertion (lower panel).
a better prognosis across the THES spectrum despite immunod-
eficiency. At 12 years of age, he will require ongoing monitoring
for the development of gastrointestinal and other systemic symp-
toms as knowledge regarding the natural history of THES through
adolescence and adulthood is lacking.
The detailed immunological evaluation of our patient sug-
gests that global innate immunity is normal in THES patients.
His normal cell counts and Toll-like receptor function are poten-
tially relevant to the evaluation of other THES patients and while
they do not exclude the diagnosis these features may help dif-
ferentiate THES from ectodermal dysplasia with immunodefi-
ciency and related disorders. Our patient’s abnormal response
to pneumococcal vaccination is reflective of humoral immune
defects in other patients with THES and may suggest a role for
TTC37 in adaptive immune function. The mechanism of defec-
tive humoral memory is not clear in this case as our patient
displayed normal B-memory cell (CD19+27+) enumeration on
several occasions and had an initial response to vaccination with
subsequent rapid decline in protective titers (Figure 2). Further
consideration of this phenotype specifically in patients with THES
will hopefully prove informative. Consideration of rapid loss of
protective antibodies can easily be overlooked in immunological
evaluations and is another important lesson to be learned from
this case.
CONCLUDING REMARKS
In summary, we present a 12-year-old male with novel compound
heterozygous variants in TTC37, abnormal antibody production
with growth and hair abnormalities who does not display typi-
cal THES-related gastrointestinal features. This case underscores
the importance of a thorough immunological evaluation and
antibody replacement therapy given the relatively high prevalence
of immunodeficiency in THES patients (3, 4, 6, 9). Additionally,
this is the first report of a patient from the United States with
THES, thereby expanding the global spectrum of this disease.
Finally, it illustrates the power of unbiased whole exome sequenc-
ing for the diagnosis of novel clinical presentations of known
inborn errors (15).
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